Benzinga | Jan 18, 2022 04:06PM EST

STRATA Skin Sciences Expands Into Israel With Leading Medical Device Distributor

STRATA Skin Sciences, Inc. (NASDAQ:SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for the treatment of dermatologic conditions, announced that it has entered into an agreement with JuvenIL, the dermatology and aesthetics portion of Trimaco, a leading distributor in Israel for medical devices and innovation, to supply STRATA's XTRAC(r) excimer lasers in Israel.

"We believe that entering into the Israeli market presents a good opportunity for STRATA," said Robert Moccia, President & CEO of STRATA Skin Sciences. "Following approval to market our products in Israel, we identified JuvenIL as the ideal partner in the region. Through JuvenIL, we can now market our products to the entire Israeli population, of which there are an estimated 300,000 psoriasis and 160,000 vitiligo patients that can benefit from our laser treatment. We are confident that JuvenIL's experienced team will be invaluable as they work with the more than forty major hospitals and four major Health Maintenance Organizations in Israel to commercialize STRATA's XTRAC excimer lasers."

JuvenIL, based in Rehovot Israel, is the dermatology and aesthetics portion of Trimaco, a company that sells cutting-edge technologies to medical centers across Israel.

"We are very excited to partner with STRATA Skin Sciences," said Liraz Shlomoff, owner and founder of Trimaco. "Their state-of-the-art excimer lasers utilized in the treatment of psoriasis, vitiligo and various other skin conditions fits well into our distribution network. We look forward to working with STRATA as they continue to expand into Israel."